Hong Kong helps speed up development of new treatments as number of clinical trials in city surges

Hong Kong is playing an increasingly important role in speeding up the registration of new pharmaceuticals and therapies globally, with the number of clinical trials conducted in the city having surged significantly in the past year, the city’s two clinical trial centres told the Post. The centres at the University of Hong Kong and Chinese University have seen a multifold increase in the number of Phase 1 clinical trials – the first of three phases before a new medication enters the...